When checking the potential of other drugs to affect BTKi-induced hypertension mechanisms, only one drug class, the Ca2+ channel blockers, showed a tSignal above the threshold set, particularly potentially reducing the ibrutinib-induced mechanism over the oxidative stress and endothelial dysfunction. The gene discussed is IBTK; the disease is hypertensive disorder.